학술논문
Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study
Document Type
Article
Author
Source
In: The Lancet HIV . (The Lancet HIV, November 2021, 8(11):e668-e678)
Subject
Language
English
ISSN
23523018